𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenetic heterogeneity in Type 1 (insulin-dependent) diabetes among Japanese — HLA antigens and organ-specific autoantibodies

✍ Scribed by K. Kida; G. Mimura; T. Kobayashi; K. Nakamura; S. Sonoda; H. Inouye; K. Tsuji

Publisher
Springer
Year
1989
Tongue
English
Weight
696 KB
Volume
32
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction of HLA and immunoglobulin an
Interaction of HLA and immunoglobulin antigens in Type 1 (insulin-dependent) diabetes
✍ L. L. Field; C. E. Andersen; K. Neiswanger; S. E. Hodge; M. A. Spence; J. I. Rot 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 657 KB

We analyzed 88 unrelated subjects with Type 1 (insulin-dependent) diabetes and 64 sibling controls (maximum one per diabetic) for associations between immunoglobulin allotype antigens (GM and KM) and Type 1 diabetes. None were found. However, we did find interactions between GM, HLA-DR, and Type 1 d

HLA-DQA1*1 contributes to resistance and
HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects
✍ K. Yamagata; T. Hanafusa; H. Nakajima; M. Sada; H. Amemiya; T. Noguchi; T. Tanak 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 566 KB

In this study HLA-DQA1 and TNF genes in addition to HLA-DQB1 gene were investigated at DNA level for elucidation of the genetic backgrounds of Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. DNA, amplified by polymerase chain reaction, was subjected to allele specific oligonucleot

Islet cell and insulin autoantibodies in
Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of Type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study
✍ C. Betterle; F. Presotto; B. Pedini; L. Moro; R. S. Slack; F. Zanette; R. Zanche 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 530 KB

To evaluate the behaviour and predictive value of islet cell and insulin autoantibodies in patients with organ-specific autoimmune diseases, we followed 21 non-diabetic subjects for a mean period of 84 +/- 27 months. Ten patients were persistently seropositive for complement-fixing islet cell antibo